Inozyme Pharma Reports Full Year 2022 Financial Results and Provides Business Highlights
– Founding CEO, Axel Bolte, MSc, MBA, to retire; Douglas A. Treco, Ph.D., to succeed…
– Founding CEO, Axel Bolte, MSc, MBA, to retire; Douglas A. Treco, Ph.D., to succeed…
Announced SC291 IND clearance with goal to report initial clinical data this year Expect to…
Announced SC291 IND clearance with goal to report initial clinical data this year Expect to…
The Company’s patent application describes how it plans to leverage cutting-edge CRISPR and mRNA technologies…
The Company’s patent application describes how it plans to leverage cutting-edge CRISPR and mRNA technologies…
Clinical updates on track for NKX101 in first half of 2023 and NKX019 in full…
Clinical updates on track for NKX101 in first half of 2023 and NKX019 in full…
Discovery of novel immune checkpoints in the tumor microenvironment with iOTarg™ screening platform Predictive biomarker…
ZUG, Switzerland and BOSTON, March 14, 2023 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical…
ZUG, Switzerland and BOSTON, March 13, 2023 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP), a…
Linea Aspesi Linea Aspesi, Executive Vice President and Chief People Officer, Editas Medicine CAMBRIDGE, Mass.,…
EMERYVILLE, Calif.–(BUSINESS WIRE)–Metagenomi, a genetic medicines company with a versatile portfolio of wholly owned, next-generation…
Reviews 2022 accomplishments; sets forth 2023 milestones and long-term vision LAWRENCEVILLE, N.J., March 01, 2023…
Reviews 2022 accomplishments; sets forth 2023 milestones and long-term vision LAWRENCEVILLE, N.J., March 01, 2023…
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
ANAHEIM, CA, Feb. 23, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – BioCorRx Inc. (OTCQB: BICX)…
Initiated the global Phase 2 study of NTLA-2002, a CRISPR-based, potential single-dose treatment for hereditary…
Trem-cel exhibited robust engraftment five months post-transplant through three cycles of Mylotarg Mylotarg treatment enriched…
Trem-cel exhibited robust engraftment five months post-transplant through three cycles of Mylotarg Mylotarg treatment enriched…
Scientists Can Now Begin the mRNA Synthesis Process from Their Own Sequence or Plasmid DNA…